| scholarly article | Q13442814 |
| P2093 | author name string | M. Essex | |
| T. H. Lee | |||
| M. L. Huang | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 | ||
| Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia | Q27861076 | ||
| Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 | ||
| Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). | Q30404166 | ||
| Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections | Q33365763 | ||
| The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4. | Q33579510 | ||
| Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. | Q33639547 | ||
| Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome | Q33649232 | ||
| Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone | Q33848331 | ||
| Isolation of a new human retrovirus from West African patients with AIDS. | Q34038984 | ||
| Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 | ||
| A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope | Q34614992 | ||
| Isolation of ras GTP-binding mutants using an in situ colony-binding assay | Q35613440 | ||
| Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects | Q36783146 | ||
| Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). | Q36800949 | ||
| Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate | Q36801331 | ||
| Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site. | Q36811030 | ||
| HIV-2 link to AIDS in West Africa | Q38142462 | ||
| Clinical experience of AIDS in relation to HIV-1 and HIV-2 infection in a rural hospital in Ivory Coast, West Africa | Q39026045 | ||
| Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein. | Q39309454 | ||
| Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa | Q39365683 | ||
| Molecular cloning and polymorphism of the human immune deficiency virus type 2. | Q39506278 | ||
| A novel proviral clone of HIV-2: biological and phylogenetic relationship to other primate immunodeficiency viruses | Q41728790 | ||
| HIV-2 antisera cross-neutralize HIV-1. | Q41985886 | ||
| A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. | Q42649286 | ||
| New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). | Q43450875 | ||
| Bacterial expression and characterization of nine polypeptides encoded by segments of the envelope gene of human immunodeficiency virus | Q43537319 | ||
| First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject | Q43662757 | ||
| Extensive variation of human immunodeficiency virus type-1 in vivo | Q43913496 | ||
| Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. | Q44238578 | ||
| Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant | Q45018234 | ||
| Bacterially produced HIV-2 env polypeptides specific for distinguishing HIV-2 from HIV-1 infections | Q45211836 | ||
| Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa | Q45840185 | ||
| A second case of the acquired immunodeficiency syndrome due to human immunodeficiency virus type 2 in the United States: the clinical implications | Q45843487 | ||
| HIV-2-associated AIDS in the United States. The first case | Q46198692 | ||
| Genomic divergence of HIV-2 from Ghana | Q46381046 | ||
| Discrimination of HIV-2 infection from HIV-1 infection by western blot and radioimmunoprecipitation analysis | Q46746463 | ||
| West African HIV-2-related human retrovirus with attenuated cytopathicity | Q46870639 | ||
| An African primate lentivirus (SIVsm) closely related to HIV-2. | Q48295012 | ||
| Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. | Q52449889 | ||
| A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. | Q53883523 | ||
| An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS. | Q54797499 | ||
| Recombinant peptides derived from the env-gene of HIV-2 in the serodiagnosis of HIV-2 infections | Q61055003 | ||
| Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies | Q67655727 | ||
| Custom-designed synthetic peptide immunoassays for distinguishing HIV type 1 and type 2 infections | Q69122024 | ||
| Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection | Q69925038 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| biology | Q420 | ||
| developed country | Q132453 | ||
| West Africa | Q4412 | ||
| immunology | Q101929 | ||
| hematologic tests | Q67067476 | ||
| microbiology | Q7193 | ||
| P304 | page(s) | 5073-5079 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope | |
| P478 | volume | 65 |
| Q37284795 | Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies |
| Q33809419 | Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection |
| Q64082780 | HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic |
| Q45788570 | Intrapatient Variability of the Human Immunodeficiency Virus Type 2 Envelope V3 Loop |
| Q60917430 | Low Postseroconversion CD4 T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection |
| Q34430673 | Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins |
Search more.